RecruitingNot ApplicableNCT05396456

Autologous Muscle Fiber Fragment Injections

Autologous Muscle Fiber Fragment Injections for the Treatment of Fecal Incontinence


Sponsor

Wake Forest University Health Sciences

Enrollment

10 participants

Start Date

Jan 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To regenerate functional anal sphincter muscle using muscle fiber fragments that contain muscle precursor cells (MPCs)


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether injecting a person's own muscle fiber fragments — which contain muscle repair cells — directly into the damaged anal sphincter muscle can improve fecal incontinence, a condition where a person cannot control bowel movements. Fecal incontinence significantly affects quality of life, and this approach aims to regenerate functional muscle tissue using the patient's own cells. Adults aged 18 and older who experience at least 4 episodes of fecal incontinence per two-week period, have had symptoms for at least 12 months, have failed standard treatments, and have a confirmed sphincter defect on ultrasound are eligible, while those with active rectal infections, inflammatory bowel disease, recent anorectal surgery, or pregnancy are excluded. Participation involves a small muscle biopsy to collect the fiber fragments, an injection procedure, and follow-up visits to assess improvement in continence. This summary was prepared to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREMuscle Fiber Fragment (MFF) Injections

The participant will be treated with an injection of muscle fiber fragments into the external anal sphincter at 3, 6, 9 and 12 o'clock using a 21-gauge needle to a depth of 1-2 cm from the external skin using equal amounts in each quadrant.


Locations(1)

Wake Forest University Health Sciences

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05396456


Related Trials